These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 5312321)

  • 21. Safety and efficacy of isoniazid chemoprophylaxis administered during liver transplant candidacy for the prevention of posttransplant tuberculosis.
    Singh N; Wagener MM; Gayowski T
    Transplantation; 2002 Sep; 74(6):892-5. PubMed ID: 12364876
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Current place of chemoprophylaxis in tuberculosis control].
    Fréour P
    Bord Med; 1971 Oct; 4(10):2763-6. PubMed ID: 5132508
    [No Abstract]   [Full Text] [Related]  

  • 23. [Active tuberculosis in children who received INH chemoprophylaxis].
    Ikeda K; Sugimori M; Kawasaki K; Kurokawa H; Kijimoto C
    Kekkaku; 1992 Oct; 67(10):653-8. PubMed ID: 1453566
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases.
    Sneag DB; Schaaf HS; Cotton MF; Zar HJ
    Pediatr Infect Dis J; 2007 Dec; 26(12):1142-6. PubMed ID: 18043453
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of the human immunodeficiency virus in the incidence of tuberculosis in a cohort of intravenous drug users: effectiveness of anti-tuberculosis chemoprophylaxis.
    Jansà JM; Serrano J; Caylà JA; Vidal R; Ocaña I; Español T
    Int J Tuberc Lung Dis; 1998 Feb; 2(2):140-6. PubMed ID: 9580481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Respective roles of BCG and isoniazid chemoprophylaxis in the prevention of tuberculosis in underdeveloped and developing countries].
    Omodei Zorini A
    Ann Sanita Pubblica; 1965; 26(4):779-86. PubMed ID: 5881717
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effectiveness of isoniazid in tuberculosis chemoprophylaxis in children with rising tuberculin sensitivity].
    Mitinskaia LA; Elufimova VF; Iukhimenko NV; Demeshko ND; Zriachkina LI; Pesnia NP
    Probl Tuberk; 1995; (2):5-6. PubMed ID: 7777467
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The role of phenotypic factors in predicting the effectiveness of pharmacological prevention of tuberculosis in children].
    Khodzitskaia VK; Zosimov AN
    Probl Tuberk; 1991; (8):19-23. PubMed ID: 1758850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Results of the first 7 years of activity of the Sardinia regional center of antitubercular chemoprophylaxis according to the Omodei Zorini method].
    Monaco A
    Lotta Tuberc; 1965; 35(5):391-400. PubMed ID: 5214067
    [No Abstract]   [Full Text] [Related]  

  • 30. Prospective randomized control trial of isoniazid chemoprophylaxis during renal replacement therapy.
    Vikrant S; Agarwal SK; Gupta S; Bhowmik D; Tiwari SC; Dash SC; Guleria S; Mehta SN
    Transpl Infect Dis; 2005; 7(3-4):99-108. PubMed ID: 16390397
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Research on BCG vaccination.
    ten Dam HG
    Adv Tuberc Res; 1984; 21():79-106. PubMed ID: 6433675
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-report INH adherence measures were reliable and valid in Latino adolescents with latent tuberculosis infection.
    Blumberg EJ; Hovell MF; Kelley NJ; Vera AY; Sipan CL; Berg JP
    J Clin Epidemiol; 2005 Jun; 58(6):645-8. PubMed ID: 15878479
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Split-drug regimens for the treatment of patients with sputum smear-positive pulmonary tuberculosis--a unique approach.
    Santha T; Rehman F; Mitchison DA; Sarma GR; Reetha AM; Prabhaker R;
    Trop Med Int Health; 2004 May; 9(5):551-8. PubMed ID: 15117298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of chemoprophylaxis on minimal pulmonary tuberculosis lesions of doubtful activity.
    Pamra SP; Mathur GP
    Bull World Health Organ; 1971; 45(5):593-602. PubMed ID: 4947493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness of directly observed chemoprophylaxis of tuberculosis among drug users at high risk for tuberculosis.
    Gourevitch MN; Alcabes P; Wasserman WC; Arno PS
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):531-40. PubMed ID: 9661818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic trial of a combination of isoniazid, rifampicin and pyrazinamide in the first 2 months of treatment of pulmonary tuberculosis].
    Bellabas M; Khaled S; Khaled NA; Boulahbal F; Chaulet P
    Rev Mal Respir; 1989; 6(1):59-64. PubMed ID: 2648511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Controlled chemoprophylaxis trials in tuberculosis. A general review.
    Ferebee SH
    Bibl Tuberc; 1970; 26():28-106. PubMed ID: 4903501
    [No Abstract]   [Full Text] [Related]  

  • 38. [Randomized control study on domestic fixed-dose combinations in the initial treatment of smears positive tuberculosis].
    Xu WG; Lu W; He HJ; Gu XR
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Oct; 27(10):690-3. PubMed ID: 16201049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drug consumption pattern in low socio-economic group in an urban community.
    Mitra J; Saha JB; Chaudhuri RN
    Indian J Public Health; 1993; 37(1):16-22. PubMed ID: 8144225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Belles-Littleman filter paper spot test.
    Eidus L; Hamilton EJ
    Am Rev Respir Dis; 1968 Apr; 97(4):722-4. PubMed ID: 5651036
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.